Stockpolly
Search
MPLT · NASDAQ · Biotechnology

MapLight Therapeutics (MPLT)

Develops circuit-selected medicines for central nervous system disorders through a clinical-stage pipeline.

$13.06
Pre-market0.00 (0.00%)
At close$13.06(−1.88%)
Watchlist

In millions of USD, except per-share figures

In millionsQ1 FY23Mar 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue00000000000
Gross profit00000000000
1219202123233131836463
Research & development1015151721202727645453
24442444191110
General & administrative24442444000
Operating income−12−19−20−21−23−24−31−31−83−65−64
00222112443
Interest income01211112222
Other non-operating income00−2−2−2−1−1−2−4−40
Income before tax−12−19−18−19−21−22−30−29−80−61−60
Net income from continuing operations−12−19−18−19−21−22−30−29−80−61−60
Net income−12−19−18−19−21−22−30−29−80−61−60
EPS, basic−$0.29−$0.46−$0.44−$0.46−$0.51−$0.54−$0.72−$0.71−$1.81−$1.34−$1.32
EPS, diluted−$0.29−$0.46−$0.44−$0.46−$0.51−$0.54−$0.72−$0.71−$1.81−$1.34−$1.32
Weighted average shares, basic4141414141414141444545
Weighted average shares, diluted4141414141414141444545
EBITDA−12−19−18−19−21−22−30−29−79−61−63
Depreciation & amortization00000000000
EBIT−12−19−18−19−21−22−30−29−80−61−64